📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Randomised, placebo-controlled, double-blinded, four-way crossover trial to demonstrate the comparative pharmacodynamic equivalence of a non-invasive diagnostic test for adrenal insufficiency in a healthy population: the STARLIT-2 study protocol. (2024)

First Author: Date KL

Attributed to: Advancing early stage healthcare research in Sheffield funded by UKRI

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2024-094830

PubMed Identifier: 39806610

Publication URI: http://europepmc.org/abstract/MED/39806610

Type: Journal Article/Review

Volume: 14

Parent Publication: BMJ open

Issue: 12

ISSN: 2044-6055